D
David S. Bredt
Researcher at Johnson & Johnson
Publications - 224
Citations - 63974
David S. Bredt is an academic researcher from Johnson & Johnson. The author has contributed to research in topics: Nitric oxide synthase & Nitric oxide. The author has an hindex of 107, co-authored 223 publications receiving 62332 citations. Previous affiliations of David S. Bredt include Johns Hopkins University & Georgetown University Medical Center.
Papers
More filters
Journal ArticleDOI
Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number
TL;DR: It is shown that AMPARs are localized to synapses through direct binding of the first two PDZ domains of synaptic PSD-95 (postsynaptic density protein of 95 kDa) to the AMPAR-associated protein, stargazin, and the central role of direct interactions between them in determining the number of synaptic AM PARs is demonstrated.
Journal ArticleDOI
Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme.
TL;DR: Macrophage NOS mRNA is strikingly inducible; it is absent in quiescent macrophages or spleen but is prominent 2-6 hr after endotoxin treatment, and the macrophage enzyme displays 50% sequence identity to the neuronal enzyme.
Journal ArticleDOI
Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP- dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; Identification of flavin and calmodulin binding sites
TL;DR: It is reported that NOS is stoichiometrically phosphorylated by cAMP dependent protein kinase, protein kinasing C, and calcium/calmodulin-dependent protein kinases, with each kinase phosphorylating a different serine site on NOS.